NMTC

0.65213.38%
ES

Edward S. Andrle

Independent Director

Mr. Edward S. Andrle, also known as Ed, serves as Independent Director at NeuroOne Medical Technologies Corporation since February 18, 2020. He serves as a Director of MD Start SA. Mr. Andrle serves as a Special Advisor to LivaNova PLC since January 1, 2020 and as General Manager of Neuromodulation from January 2018 to January 1, 2020. Mr. Andrle served as Senior Vice President of Strategy & Business Development at LivaNova PLC from September 2015 to January 2018. He is also a member of the Board of Rainbow Medical, a medical device incubator in Israel, since August 2020. Mr. Andrle served as Senior Vice President of Strategy and Business Development at Sand Holdco PLC. He served as Vice-President of Strategy & Business Development at Sorin SpA (Sorin Group) from 2010 to September 2015. He served as Vice President of Business Development at Sorin SpA (a/k/a, Sorin Group) in Milan, Italy. Prior to Sorin, he co-founded, developed, and sold three medical device companies in the Minneapolis area. He also served for five years as a Vice President of Boston Scientific, where he led a new business unit focused on peripheral vascular catheters and guidewires. He was an Entrepreneur and Chief Executive Officer of start-up companies like Teramed (endovascular stent-graft), Myocor (mitral valve surgery) and StarFire Medical (neurovascular technology). He also worked for Institutional Venture Partners in medical device investments and spent five years at Baxter International working in marketing in the renal therapy business. He had a successful career in the medical device industry. Mr. Andrle served as a Director of Respicardia, Inc., until January 2018. He holds an MBA from the Stanford Graduate School of Business and a BS in Chemical Engineering from the University of Notre Dame.

Positions